Boston Scientific Pre-Tax Income 2010-2024 | BSX

Boston Scientific annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Boston Scientific pre-tax income for the quarter ending September 30, 2024 was $0.669B, a 9.67% increase year-over-year.
  • Boston Scientific pre-tax income for the twelve months ending September 30, 2024 was $2.202B, a 17.44% increase year-over-year.
  • Boston Scientific annual pre-tax income for 2023 was $1.985B, a 73.97% increase from 2022.
  • Boston Scientific annual pre-tax income for 2022 was $1.141B, a 6.04% increase from 2021.
  • Boston Scientific annual pre-tax income for 2021 was $1.076B, a 1462.03% decline from 2020.
Boston Scientific Annual Pre-Tax Income
(Millions of US $)
2023 $1,985
2022 $1,141
2021 $1,076
2020 $-79
2019 $687
2018 $1,422
2017 $933
2016 $177
2015 $-650
2014 $-509
2013 $-223
2012 $-4,107
2011 $642
2010 $-1,063
2009 $-1,308
Boston Scientific Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $669
2024-06-30 $420
2024-03-31 $608
2023-12-31 $505
2023-09-30 $610
2023-06-30 $426
2023-03-31 $444
2022-12-31 $395
2022-09-30 $245
2022-06-30 $345
2022-03-31 $156
2021-12-31 $119
2021-09-30 $483
2021-06-30 $149
2021-03-31 $325
2020-12-31 $307
2020-09-30 $-227
2020-06-30 $-181
2020-03-31 $22
2019-12-31 $-6
2019-09-30 $91
2019-06-30 $145
2019-03-31 $457
2018-12-31 $296
2018-09-30 $456
2018-06-30 $347
2018-03-31 $323
2017-12-31 $228
2017-09-30 $309
2017-06-30 $91
2017-03-31 $305
2016-12-31 $89
2016-09-30 $257
2016-06-30 $-397
2016-03-31 $228
2015-12-31 $-337
2015-09-30 $-367
2015-06-30 $105
2015-03-31 $-51
2014-12-31 $-554
2014-09-30 $3
2014-06-30 $-104
2014-03-31 $146
2013-12-31 $59
2013-09-30 $-40
2013-06-30 $152
2013-03-31 $-394
2012-12-31 $51
2012-09-30 $-663
2012-06-30 $-3,618
2012-03-31 $123
2011-12-31 $100
2011-09-30 $111
2011-06-30 $158
2011-03-31 $273
2010-12-31 $230
2010-09-30 $163
2010-06-30 $119
2010-03-31 $-1,575
2009-12-31 $-1,347
2009-09-30 $-44
2009-06-30 $180
2009-03-31 $-97
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $133.131B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.157B 25.91
Stryker (SYK) United States $148.171B 33.39
EssilorLuxottica (ESLOY) France $113.461B 0.00
Medtronic (MDT) Ireland $109.010B 16.19
Haleon (HLN) United Kingdom $42.913B 27.88
Lonza Group Ag (LZAGY) Switzerland $42.122B 0.00
GE HealthCare Technologies (GEHC) United States $37.701B 19.56
ResMed (RMD) United States $34.955B 28.72
Terumo (TRUMY) Japan $29.203B 41.24
Koninklijke Philips (PHG) Netherlands $24.410B 18.68
Zimmer Biomet Holdings (ZBH) United States $22.087B 14.06
Insulet (PODD) United States $18.377B 73.18
Baxter (BAX) United States $16.604B 10.80
Smith & Nephew SNATS (SNN) United Kingdom $11.153B 0.00
BellRing Brands (BRBR) United States $9.468B 37.96
Bio-Rad Laboratories (BIO) United States $8.977B 30.51
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $5.523B 12.83
TG Therapeutics (TGTX) United States $4.720B 0.00
Haemonetics (HAE) United States $4.260B 20.79
ICU Medical (ICUI) United States $4.155B 39.56
Prestige Consumer Healthcare (PBH) United States $4.074B 20.26
Perrigo (PRGO) Ireland $3.716B 10.94
Envista Holdings (NVST) United States $3.487B 25.97
Neogen (NEOG) United States $3.270B 37.72
Agios Pharmaceuticals (AGIO) United States $3.103B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.789B 17.89
QuidelOrtho (QDEL) United States $2.595B 16.70
Warby Parker (WRBY) United States $2.344B 0.00
LeMaitre Vascular (LMAT) United States $2.332B 56.69
Green Thumb Industries (GTBIF) United States $1.964B 34.37
AtriCure (ATRC) United States $1.772B 0.00
InMode (INMD) Israel $1.487B 8.94
Curaleaf Holdings (CURLF) Canada $1.348B 0.00
AdaptHealth (AHCO) United States $1.311B 9.37
Maravai LifeSciences Holdings (MRVI) United States $1.168B 0.00
BioLife Solutions (BLFS) United States $1.041B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.957B 7.48
CeriBell (CBLL) United States $0.916B 0.00
National Vision Holdings (EYE) United States $0.888B 29.68
Capricor Therapeutics (CAPR) United States $0.839B 0.00
Evolus (EOLS) United States $0.785B 0.00
Verano Holdings (VRNOF) United States $0.608B 0.00
Cresco Labs (CRLBF) United States $0.596B 0.00
VAREX IMAGING (VREX) United States $0.596B 26.47
Surmodics (SRDX) United States $0.559B 0.00
Quanterix (QTRX) United States $0.424B 0.00
Canopy Growth (CGC) Canada $0.404B 0.00
Valneva SE (VALN) France $0.370B 0.00
ZimVie (ZIMV) United States $0.363B 30.63
Omeros (OMER) United States $0.349B 0.00
Viemed Healthcare (VMD) United States $0.335B 31.89
Biote (BTMD) United States $0.330B 7.25
Sanara MedTech (SMTI) United States $0.323B 0.00
Cerus (CERS) United States $0.312B 0.00
OraSure Technologies (OSUR) United States $0.288B 19.30
Zynex (ZYXI) United States $0.249B 52.13
TerrAscend (TSNDF) Canada $0.243B 0.00
Aurora Cannabis (ACB) Canada $0.229B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.15
MacroGenics (MGNX) United States $0.218B 0.00
High Tide (HITI) Canada $0.215B 89.00
Sanuwave Health (SNWV) United States $0.195B 2.74
Jin Medical (ZJYL) China $0.188B 0.00
Zevia PBC (ZVIA) United States $0.162B 0.00
Brainsway (BWAY) Israel $0.161B 96.70
Organigram Holdings (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.143B 17.98
TriSalus Life Sciences (TLSI) United States $0.126B 0.00
Quipt Home Medical (QIPT) United States $0.106B 0.00
Fonar (FONR) United States $0.093B 10.54
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.00
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.082B 0.00
Rockwell Medical (RMTI) United States $0.080B 41.50
Modular Medical (MODD) United States $0.073B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Cellectar Biosciences (CLRB) United States $0.066B 0.00
InterCure (INCR) Israel $0.063B 0.00
Exagen (XGN) United States $0.062B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
Apyx Medical (APYX) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.026B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.17
SNDL (SNDL) Canada $0.000B 0.00